McKesson (MCK)
(Delayed Data from NYSE)
$543.30 USD
+3.36 (0.62%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $543.18 -0.12 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MCK 543.30 +3.36(0.62%)
Will MCK be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MCK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MCK
McKesson (MCK) Rises But Trails Market: What Investors Should Know
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
MCK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Other News for MCK
ClearBridge Global Growth Strategy Q1 2024 Portfolio Manager Commentary
June 7th Options Now Available For McKesson Corp (MCK)
Dividend Roundup: MetLife, General Motors, Pfizer, Citigroup, and more
McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies